Ion beam therapy with concurrent hepatic arterial infusion chemotherapy for advanced HCC, PhaseI/II study

Ion beam therapy with concurrent hepatic arterial infusion chemotherapy for advanced HCC, PhaseI/II study - Ion beam therapy with concurrent hepatic arterial infusion chemotherapy for advanced HCC

Status

Unknown

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000002172

Enrollment

Registered

2009-07-14

Start date

2009-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hepatocellular carcinoma

Interventions

Hepatic arterial infusion chemotherapy Ion beam therapy(proton therapy, carbon-ion therapy)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Unresectable HCC with tumor thronbosis and multiple intrahepatic metastases

Exclusion criteria

Exclusion criteria: Distal metastases Acsites

Design outcomes

Primary

Measure	Time frame
side effect, survival time and QOL	—

Countries

Japan

Contacts

Public ContactKazuki Terashima

Hyogo Ion Beam Medical Center Department of Radiology

terashima@kmyr.jp0791-58-0100

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026